Why Medtronic plc (MDT) stock moved
Medtronic plc (MDT) shares rose 1.0% to $92.02 as of August 27, 2026, a slight gain from the prior close of $91.14. BestStocks flagged the session as a major change for MDT. Below, we break down what changed for MDT, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
MDT climbed 1.0% to $92.02
Medtronic rose 2.05% to $93.98 in intraday trading, outperforming a declining broader market (per Zacks report from 2026-08-18). Volume of 3.3 million shares ran at 0.56x the historical average for this time of day, suggesting below-average participation in the advance. Medtronic earnings release on 2026-08-25; watch for EPS beat/miss vs. $1.39 consensus and any forward guidance or commentary on demand in core medical-device segments.
What it means for Medtronic plc investors
For Medtronic plc investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 1.0% session move. Weighing against that: Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $93.85, implying +2.0% upside from $92.02. Over the past 90 days analysts logged 2 upgrades and 0 downgrades. BestStocks rates the overall signal quality weak (28/100). With earnings roughly 5 days out, the next report is the most likely near-term test of the move.
MDT price reaction
MDT last traded at $92.02, up $0.88 (+0.97%) from the previous close of $91.14. The session traded on 0.7× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $84.22 and $94.13, and it currently sits about 79% of the way up that band.
Bullish and bearish analyst opinions on Medtronic plc (MDT)
The consensus analyst price target on Medtronic plc (MDT) is $93.85, 2.0% above the recent $92.02. Over the past 90 days analysts logged 2 upgrades, 14 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MDT line up.
The bullish case
- Wall Street's consensus price target of $93.85 implies +2.0% upside from $92.02.
- The Street's most bullish target is $119.00 (+29.3%).
- 2 analyst upgrades in the past 90 days, most recently UBS to Buy (2026-07-28).
- Material positive event.
- Positive 1.0% session move.
The bearish case
- The most bearish analyst target is $80.00 (-13.1%).
- Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14.
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 27, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for MDT
Frequently asked questions about MDT
Why did Medtronic plc (MDT) stock move?
MDT rose 1.0% to $92.02. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did MDT stock rise?
MDT gained 0.97% ($0.88) versus the prior close of $91.14, last trading at $92.02 on 0.7× average volume.
When is Medtronic plc's next earnings date?
MDT's next earnings report is estimated for 2026-09-01 — about 5 days away.
What is the analyst price target for MDT?
The consensus analyst price target for MDT is $93.85, about 2.0% above the current $92.02. Over the past 90 days, analysts recorded 2 upgrades, 14 maintains, and 0 downgrades.
How BestStocks tracks MDT
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared MDT-specific materiality thresholds, triggering an evidence check. It draws on 18 tracked change events for MDT, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 27, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
